Karen A. Dawes - Jun 14, 2024 Form 4/A Insider Report for REPLIGEN CORP (RGEN)

Role: Director
Signature: /s/ Kenneth O'Brien (Attorney in Fact)
Stock symbol: RGEN
Transactions as of: Jun 14, 2024
Transactions value $: $0
Form type: 4/A
Date filed: 8/19/2024, 07:29 PM
Date Of Original Report: Jun 14, 2024
Previous filing: May 20, 2024

Transactions Table

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Ownership	Footnotes
holding	RGEN	Common Stock						91.1K	Jun 14, 2024	Direct

* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Remarks:

This Form 4/A amends a Form 4 filed on 6/14/2024 to correct an administrative error, which misreported the number of shares beneficially owned by the reporting person. The correction reflects an increase in the number of shares beneficially owned by the reporting person by 2,953 shares. Exhibit 24.1: Power of Attorney